Lustgarten Foundation   Report issue

Foundation Phase 1 Phase 2
Founded: Woodbury NY United States (1998)

Organization Overview

First Clinical Trial
2015
NCT02179970
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Lustgarten Foundation